About Atria Clinical Research
Clinical Trials at Atria Clinical Research
During the past decade, Atria Clinical Research conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 9 clinical trials were completed, i.e. on
average, 60% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 9 clinical trials were completed. i.e. 128.6%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Atria Clinical Research" #1 sponsor was "Shire" with 5 trials, followed by "Biohaven Pharmaceuticals, Inc." with 2 trials
sponsored, "Phathom Pharmaceuticals, Inc." with 2 trials sponsored, "Boehringer Ingelheim" with 1 trials sponsored and "Ironwood Pharmaceuticals, Inc."
with 1 trials sponsored. Other sponsors include -1 different institutions and
companies that sponsored additional 9 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Atria Clinical Research"
#1 collaborator was "H. Lundbeck A/S" with 1 trials as a collaborator and "TIMI Study Group" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Atria Clinical Research
According to Clinical.Site data, the most researched conditions in "Atria Clinical Research" are
"Crohn's Disease" (3 trials), "Ulcerative Colitis" (3 trials), "Alzheimer Disease" (1 trials), "Bipolar I Disorder" (1 trials) and "Cow's Milk Allergy" (1 trials). Many other conditions were trialed in "Atria Clinical Research" in a lesser frequency.
Clinical Trials Intervention Types at Atria Clinical Research
Most popular intervention types in "Atria Clinical Research" are "Drug" (13 trials), "Other" (5 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (9 trials), "Ontamalimab" (4 trials), "Lansoprazole" (2 trials), "Vonoprazan" (2 trials) and "25 mg Ontamalimab" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Atria Clinical Research
The vast majority of trials in "Atria Clinical Research" are
15 trials for "All" genders.
Clinical Trials Status at Atria Clinical Research
Currently, there are NaN active trials in "Atria Clinical Research".
undefined are not yet recruiting,
1 are recruiting,
2 are Active, not recruiting,
and 1 are Enrolling by invitation.
In total, there were 8 completed trials in Atria Clinical Research,
undefined suspended trials,
and 3 terminated clinical trials to date.
Out of the total trials that were conducted in Atria Clinical Research, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 12 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 1 trials that are defined as “Not Applicable".